ArticleCureus2025
Clinical Assessment of Potential Difference in Motion-Tracking Irradiation for Liver Tumors Using Radixact Synchrony®.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to advance the precision of motion-managed radiotherapy and provide robust information for clinical practice in terms of necessary margins using Radixact Synchrony® (Accuray, Sunnyvale, USA). A retrospective analysis was conducted on 88 irradiation sessions in nine cases of motion-tracking irradiation for liver tumors. Two gold markers were placed near the tumor, and a planning target volume (PTV) margin of 5 mm was set. The interruption threshold for potential difference (PD) (the statistical prediction value of the three-dimensional (3D) distance error from the predictive model) was set at 3.0 mm during treatment. PDvalues obtained before and during treatment, as well as the number of interruptions, were analyzed. A multiple regression analysis was performed to evaluate the influence of various planning parameters, which were obtained during four-dimensional (4D) treatment planning, on the 95th percentile value of PD (PD
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.